The introduction of the drug in Australia is creating significant buzz within the weight loss community. This novel dual compound – targeting both GLP-1 and GIP targets – presents a potentially powerful approach https://australianpeptidestore.co/bpc-157-10mg-research-peptide-australian-peptide-store/